The FOXO3a transcription factor is a target of cell survival and proliferative signaling by the NPM-ALK fusion kinase of anaplastic large cell lymphoma.

被引：0
|
作者：
Sternberg, DW
Gu, TL
Tothova, Z
Scheijen, B
Griffin, JD
Gilliland, DG
机构：
[1] Brigham & Womens Hosp, Div Hematol, Boston, MA 02115 USA
[2] Harvard Univ, Sch Med, Howard Hughes Med Inst, Boston, MA 02115 USA
[3] Dana Farber Canc Inst, Boston, MA 02115 USA
来源：
BLOOD | 2003年 / 102卷 / 11期
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
78
引用
收藏
页码：25A / 25A
页数：1
相关论文
共 50 条
  • [41] Analysis of gene expression profile of TPM3-ALK positive anaplastic large cell lymphoma reveals overlapping and unique patterns with that of NPM-ALK positive anaplastic large cell lymphoma
    Bohling, Sandra D.
    Jenson, Stephen D.
    Crockett, David K.
    Schumacher, Jonathan A.
    Elenitoba-Johnson, Kojo S. J.
    Lim, Megan S.
    LEUKEMIA RESEARCH, 2008, 32 (03) : 383 - 393
  • [42] Frequent expression of the NPM-ALK chimeric fusion protein in anaplastic large-cell lymphoma, lympho-histiocytic type
    Pileri, SA
    Pulford, K
    Mori, S
    Mason, DY
    Sabattini, E
    Roncador, G
    Piccioli, M
    Ceccarelli, C
    Piccaluga, PP
    Santini, D
    Leone, O
    Stein, H
    Falini, B
    AMERICAN JOURNAL OF PATHOLOGY, 1997, 150 (04): : 1207 - 1211
  • [43] NPM-ALK expression levels identify two distinct subtypes of paediatric anaplastic large cell lymphoma
    E Pomari
    G Basso
    S Bresolin
    M Pillon
    E Carraro
    E S d'Amore
    G Viola
    C Frasson
    K Basso
    P Bonvini
    L Mussolin
    Leukemia, 2017, 31 : 498 - 501
  • [44] NPM-ALK phosphorylates WASp Y102 and contributes to oncogenesis of anaplastic large cell lymphoma
    C A Murga-Zamalloa
    V Mendoza-Reinoso
    A A Sahasrabuddhe
    D Rolland
    S R Hwang
    S R P McDonnell
    A P Sciallis
    R A Wilcox
    V Bashur
    K Elenitoba-Johnson
    M S Lim
    Oncogene, 2017, 36 : 2085 - 2094
  • [45] TRANSCRIPTS OF THE NPM-ALK FUSION GENE IN ANAPLASTIC LARGE-CELL LYMPHOMA, HODGKINS-DISEASE, AND REACTIVE LYMPHOID LESIONS
    ELMBERGER, PG
    LOZANO, MD
    WEISENBURGER, DD
    SANGER, W
    CHAN, WC
    BLOOD, 1995, 86 (09) : 3517 - 3521
  • [46] Activation of Rac1 and the exchange factor Vav3 are involved in NPM-ALK signaling in anaplastic large cell lymphomas
    A Colomba
    D Courilleau
    D Ramel
    D D Billadeau
    E Espinos
    G Delsol
    B Payrastre
    F Gaits-Iacovoni
    Oncogene, 2008, 27 : 2728 - 2736
  • [47] Activation of Rac1 and the exchange factor Vav3 are involved in NPM-ALK signaling in anaplastic large cell lymphomas
    Colomba, A.
    Courilleau, D.
    Ramel, D.
    Billadeau, D. D.
    Espinos, E.
    Delsol, G.
    Payrastre, B.
    Gaits-Iacovoni, F.
    ONCOGENE, 2008, 27 (19) : 2728 - 2736
  • [48] NPM-ALK expression levels identify two distinct subtypes of paediatric anaplastic large cell lymphoma
    Pomari, E.
    Basso, G.
    Bresolin, S.
    Pillon, M.
    Carraro, E.
    d'Amore, E. S.
    Viola, G.
    Frasson, C.
    Basso, K.
    Bonvini, P.
    Mussolin, L.
    LEUKEMIA, 2017, 31 (02) : 498 - 501
  • [49] NPM-ALK phosphorylates WASp Y102 and contributes to oncogenesis of anaplastic large cell lymphoma
    Murga-Zamalloa, C. A.
    Mendoza-Reinoso, V.
    Sahasrabuddhe, A. A.
    Rolland, D.
    Hwang, S. R.
    McDonnell, S. R. P.
    Sciallis, A. P.
    Wilcox, R. A.
    Bashur, V.
    Elenitoba-Johnson, K.
    Lim, M. S.
    ONCOGENE, 2017, 36 (15) : 2085 - 2094
  • [50] NPM-ALK Is a Key Regulator of the Oncoprotein FOXM1 in ALK-Positive Anaplastic Large Cell Lymphoma
    Haque, Moinul
    Li, Jing
    Huang, Yung-Hsing
    Almowaled, Meaad
    Barger, Carter J.
    Karpf, Adam R.
    Wang, Peng
    Chen, Will
    Turner, Suzanne D.
    Lai, Raymond
    CANCERS, 2019, 11 (08)
12345